News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Noninvasive Vagus Nerve Stimulation for Migraine and Primary Headache Disorders: Efficacy, Cost, and Impact on Quality of Life

Review of Evidence on Noninvasive Vagus Nerve Stimulation for Treatment of Migraine: Efficacy, Safety, and Implications

ByMkaya Mwamburi, MD, PhD,Andrew T. Tenaglia, BA,Eric J. Leibler,Peter S. Staats, MD, MBA

December 13th 2018

Noninvasive Vagus Nerve Stimulation in a Primary Care Setting: Effects on Quality of Life and Utilization Measures in Multimorbidity Patients With or Without Primary Headache

ByIain Strickland, PhD, BSc,Mkaya Mwamburi, MD, PhD,Steven Davis BSc,James C.R. Ward, MBBS,Janet Day, MBChB,Andrew T. Tenaglia, BA,Eric J. Leibler,Peter S. Staats, MD, MBA

December 13th 2018

Participating Faculty

By

December 13th 2018

Cost-effectiveness of Noninvasive Vagus Nerve Stimulation for Acute Treatment of Episodic Migraine and Role in Treatment Sequence Strategies

ByMkaya Mwamburi, MD, PhD,Andrew T. Tenaglia, BA,Eric J. Leibler,Peter S. Staats, MD, MBA

December 13th 2018

Trending on AJMC

Communication of Launch Prices by Drug Companies, 2022-2024

Top 5 Most-Read News Stories of 2025

Bispecifics in New Combos, New Uses, and Earlier Lines of Treatment in Myeloma

FDA Approves Once-Monthly PCSK9 Injection for LDL-C Reduction

FDA to Accept De-Identified Real-World Evidence for Select Medical Device Applications

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.